Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis
Authors
Keywords
-
Journal
American Journal of Cardiovascular Drugs
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-12
DOI
10.1007/s40256-020-00439-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
- (2020) Jin-jin Zhang et al. ALLERGY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
- (2020) Yanan Cao et al. Cell Discovery
- Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
- (2020) Bolin Wang et al. Aging-US
- Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
- (2020) Chia Siang Kow et al. American Journal of Cardiovascular Drugs
- COVID-19 with Different Severities: A Multicenter Study of Clinical Features
- (2020) Yun Feng et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin–angiotensin system inhibitors
- (2020) Xian Zhou et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study
- (2020) Sun-Young Jung et al. CLINICAL INFECTIOUS DISEASES
- Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
- (2020) Bo Li et al. Clinical Research in Cardiology
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
- (2020) Yuchen Chen et al. DIABETES CARE
- Associations between Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality among Patients with COVID-19
- (2020) Nian-Di Tan et al. GASTROENTEROLOGY
- Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
- (2020) Guang Yang et al. HYPERTENSION
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
- (2020) Matt Arentz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
- (2020) Xiaochen Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome
- (2020) Jianhua Hu et al. JOURNAL OF INFECTION
- Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis
- (2020) Carlos J. Pirola et al. JOURNAL OF INFECTION
- Ramipril in High Risk Patients with COVID-19
- (2020) Ignacio J. Amat-Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
- (2020) Pavan K. Bhatraju et al. NEW ENGLAND JOURNAL OF MEDICINE
- 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study
- (2020) Andrea Giacomelli et al. PHARMACOLOGICAL RESEARCH
- Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series
- (2020) Michael G Argenziano et al. BMJ-British Medical Journal
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Neil Mehta et al. JAMA Cardiology
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
- (2020) Shaobo Shi et al. JAMA Cardiology
- The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
- (2020) Zheyong Huang et al. Annals of Translational Medicine
- Meta-analysis of Effectiveness of Statins in Patients with Severe COVID-19
- (2020) Chia Siang Kow et al. AMERICAN JOURNAL OF CARDIOLOGY
- Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives
- (2020) Carla Felice et al. AMERICAN JOURNAL OF HYPERTENSION
- Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography
- (2020) Giuseppe Ferrante et al. CARDIOVASCULAR RESEARCH
- In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
- (2020) Xiao-Jing Zhang et al. Cell Metabolism
- Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?
- (2020) Murat Selçuk et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France
- (2020) Abderrahim Oussalah et al. CLINICAL INFECTIOUS DISEASES
- Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study
- (2020) Chao Gao et al. EUROPEAN HEART JOURNAL
- Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
- (2020) Maria Elena Flacco et al. HEART
- Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
- (2020) Feng Zhou et al. HYPERTENSION
- Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
- (2020) Emil L. Fosbøl et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Use of inhibitors of the renin‐angiotensin system in hypertensive patients and COVID‐19 severity: A systematic review and meta‐analysis
- (2020) Jessica Barochiner et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients
- (2020) Priyank Shah et al. JOURNAL OF HYPERTENSION
- In-hospital Use of ACEI/ARB is associated with lower Risk of Mortality and Critic Illness in COVID-19 Patients with Hypertension
- (2020) Yuan Yuan et al. JOURNAL OF INFECTION
- Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID‐19 patients in Michigan, United States
- (2020) Z. Imam et al. JOURNAL OF INTERNAL MEDICINE
- ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis
- (2020) Xue Zhang et al. PHARMACOLOGICAL RESEARCH
- Could anti‐hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID‐19 infection? Data from centers of southern Italy
- (2020) Celestino Sardu et al. Journal of the American Heart Association
- Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
- (2020) Giacomo Grasselli et al. JAMA Internal Medicine
- Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis
- (2020) Syed Shahzad Hasan et al. Expert Review of Respiratory Medicine
- Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
- (2020) Jiuyang Xu et al. Frontiers of Medicine
- Association between renin–angiotensin system inhibitors and COVID-19 complications
- (2020) Sophie Liabeuf et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Outcomes of renin–angiotensin–aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis
- (2020) Antonio Greco et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality
- (2020) Francesco Cannata et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19 in critically ill elderly patients
- (2020) Christian Jung et al. European Heart Journal-Cardiovascular Pharmacotherapy
- A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
- (2020) Abhinav Grover et al. European Heart Journal-Cardiovascular Pharmacotherapy
- The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study
- (2020) Rinkoo Dalan et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea
- (2020) Minkook Son et al. HYPERTENSION
- Mortality in COVID-19 patients treated with ACEIs/ARBs: Re-estimated meta-analysis results following the Mehra et al. retraction
- (2020) Ahmad Alamer et al. PHARMACOLOGICAL RESEARCH
- Mortality and Pre‐Hospitalization use of Renin‐Angiotensin System Inhibitors in Hypertensive COVID‐19 Patients
- (2020) Chen Chen et al. Journal of the American Heart Association
- Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis
- (2019) Jay Ramchand et al. JACC-Cardiovascular Imaging
- Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease
- (2018) Jay Ramchand et al. PLoS One
- Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats
- (2015) Jan Klimas et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
- (2014) M. Furuhashi et al. AMERICAN JOURNAL OF HYPERTENSION
- Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
- (2014) Raphael N. Vuille-dit-Bille et al. AMINO ACIDS
- Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor–Dependent Mechanism
- (2014) Matthew R. Deshotels et al. HYPERTENSION
- Combination renin–angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions
- (2012) Luke J. Burchill et al. CLINICAL SCIENCE
- Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression
- (2010) Jiu-Chang Zhong et al. REGULATORY PEPTIDES
- Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes
- (2009) Slava Epelman et al. JOURNAL OF CARDIAC FAILURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started